Unigene to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011

^{Published on Thursday, November 10th 2011 at 5:16 GMT by Market Wire}  

Unigene to Present at the Lazard Capital Markets 8th Annual Healthcare Conference... -- BOONTON, N.J., Nov. 10, 2011 /PRNewswire/ --

BOONTON, N.J., Nov. 10, 2011 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced that Ashleigh Palmer, President and Chief Executive Officer will be presenting a corporate overview at the Lazard Capital Markets 8th Annual Healthcare Conference. Mr. Palmer's live presentation is scheduled to begin at 1:00 p.m. ET on Wednesday, November 16, 2011.

Individuals can listen to a live webcast of the presentation by logging on to the Investors and Media section under the Events tab of the Unigene web site, [ http://www.unigene.com ]. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.

About Unigene Laboratories, Inc.:

Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Investor Contact:
Unigene Laboratories, Inc.
Jenene Thomas
VP, Investor Relations and Business Administration
973-265-1107
[ jthomas@unigene.com ]

Media Contact:
Tiberend Strategic Advisors, Inc.
Jason Rando / Andrew Mielach
212-827-0020
[ jrando@tiberend.com ] / [ amielach@tiberend.com ]

SOURCE Unigene Laboratories, Inc.

RELATED LINKS
[ http://www.unigene.com ]